Understand the source comparison
Do Peptides Help With Gut Health?: Clinical vs Supplement Comparison
BPC-157 peptide VEGF upregulation, angiogenesis enhancement, tight junction stabilization Preclinical animal models (high quality), human case reports (limited) Direct epithelial regeneration demonstrated in rodent IBD models 10 mcg/kg (rodent), extrapolated 2
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157 peptide
- VEGF upregulation, angiogenesis enhancement, tight junction stabilization
- Preclinical animal models (high quality), human case reports (limited)
- Direct epithelial regeneration demonstrated in rodent IBD models
- 10 mcg/kg (rodent), extrapolated 200–500 mcg (human)
- Strongest preclinical evidence for mucosal healing; lacks Phase 3 human trials
- KPV peptide
- NF-κB pathway inhibition, cytokine suppression (TNF-α, IL-6, IL-8)
- In vitro cellular studies, early animal models
- Indirect via inflammation reduction; does not directly rebuild tight junctions
- 500 mcg–2 mg (estimated human dose from cellular work)
- Compelling anti-inflammatory mechanism; minimal human dosing data
- L-glutamine
- Enterocyte fuel source, heat shock protein expression
- Meta-analyses in critical care populations, mixed results in healthy adults
- Supports cell turnover; does not repair damaged tight junction proteins
- 10–30 grams daily (oral)
- Established role in catabolic states; limited gut-specific barrier evidence
- Probiotics (multi-strain)
- Microbial competition, short-chain fatty acid production, immune modulation
- Extensive RCTs; highly strain-dependent outcomes
- Indirect via immune signaling; no direct tight junction repair
- 10–100 billion CFU daily
- Well-tolerated; efficacy varies wildly by strain and condition
- Zinc carnosine
- Mucus layer stabilization, antioxidant activity
- Small human RCTs in gastric ulcer models
- Protects existing barrier; unclear regenerative capacity
- 75–150 mg twice daily
- Modest evidence for gastric protection; limited intestinal barrier data
- The comparison underscores a critical distinction: peptides target cellular repair mechanisms directly, while most gut supplements modulate the environment or provide substrates. Neither approach is superior in all contexts—acute barrier damage may benefit more from peptide intervention, while long-term microbiome balance requires broader strategies.